Clinical Trials on Recurrent Malignant Peripheral Nerve Sheath Tumor in Portugal
Total 18 results
-
Novartis PharmaceuticalsRecruitingNewly Diagnosed and Recurrent GlioblastomaSpain, Israel, Portugal
-
Novartis PharmaceuticalsCompletedMalignant MelanomaPortugal
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
University of CoimbraCompletedAutism Spectrum Disorder | Neurofibromatosis 1Portugal
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Infant Neuroblastoma Study Group - 1999CompletedCombination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.NeuroblastomaSwitzerland, Denmark, Spain, Belgium, France, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
European Infant Neuroblastoma Study Group - 1999CompletedNeuroblastomaSwitzerland, Denmark, Spain, United Kingdom, Belgium, France, Austria, Italy, Norway, Portugal, Sweden
-
Societe Internationale d'Oncologie PediatriqueChildren's Cancer and Leukaemia GroupCompletedNeuroblastomaSwitzerland, Spain, Germany, Belgium, France, Denmark, Austria, Italy, Norway, Portugal, Sweden, United Kingdom
-
PfizerTerminatedNeuroblastomaAustralia, Korea, Republic of, United States, Portugal, New Zealand, Sweden
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
University of LeicesterUnknownNeuroblastomaIreland, United Kingdom, France, Switzerland, Austria, Italy, Spain, Norway, Belgium, Denmark, Israel, Portugal, Sweden
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
AstraZenecaRecruitingNeurofibromatosis Type 1Spain, United Kingdom, Israel, France, Italy, Portugal, Switzerland, Germany, Austria
-
St. Anna KinderkrebsforschungRecruitingNeuroblastomaNorway, Czechia, United Kingdom, France, Spain, Belgium, Switzerland, Hungary, Israel, Australia, Italy, Austria, Denmark, Greece, Ireland, Poland, Portugal, Slovakia, Slovenia, Sweden
-
Novartis PharmaceuticalsCompletedMalignant MelanomaCanada, Italy, Czechia, Australia, France, Greece, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Slovakia, Slovenia, Japan, Turkey, Argentina, Finland, Norway, Brazil, Latvia, Lithuania, Poland, Portugal
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Actuate Therapeutics Inc.Active, not recruitingSarcoma | Cancer | Breast Neoplasms | Neoplasm Metastasis | Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Bone Cancer | Malignant Glioma | Bone Metastases | Pancreas Cancer | Renal Cancer | Refractory Non-Hodgkin Lymphoma | Bone Neoplasm | Neoplasm, Breast | Refractory Cancer | Refractory Neoplasm | Resistant... and other conditionsUnited States, Belgium, Canada, Spain, France, Netherlands, Portugal